Day: May 27, 2020

CAMBRIDGE, Mass. and NEW YORK, May 27, 2020 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic therapies, today announced that its President and Chief Executive Officer, David M. Epstein, Ph.D., will present an update about the Company’s business at the Jefferies Virtual Healthcare Conference. The presentation will take place on Wednesday, June 3, 2020, at 1:30 PM ET.A live webcast of the presentation can be accessed by visiting the investor relations section of the Company’s website, www.blackdiamondtherapeutics.com. A replay of the presentation will also be available and archived on the site for three weeks.About Black DiamondBlack Diamond Therapeutics is a precision oncology medicine company pioneering...

Maranello (Italy), 27 May 2020 – Ferrari N.V. (NYSE/MTA: RACE) announces the settlement of the offering, previously announced, of Euro 650 million in aggregate principal amount of 1.500% notes due in May 2025, with an issue price of 98.898% (the “Notes”). The net proceeds of the offering were approximately Euro 641 million after payment of offering and related expenses. The Notes have been admitted to the Official List of Euronext Dublin and to trading on the regulated market of Euronext Dublin.The prospectus related to the Notes, dated 21 May 2020, was approved by the Central Bank of Ireland and it has been published on the Ferrari N.V. corporate website together with other relevant documents.AttachmentFNV 2020 DRS – Settlement PR (ENG) Final

FREDERICTON, New Brunswick , May 27, 2020 (GLOBE NEWSWIRE) — Trius Investments Inc. (TSXV:TRU.H) (“Trius”) announces that, subject to regulatory approval, it has granted an aggregate of 950,000 incentive stock options (“Options”) to its independent directors in accordance with Trius’ stock option plan. These Options have a five-year term and an exercise price of $0.105 each, and vest immediately. The Options, and any common shares of Trius that may be issued upon their exercise, are subject to a hold period expiring four months and one day after the date of grant of the Options.About Trius Investments Inc.Trius is an investment issuer searching for new investments and/or business opportunities. Trius’ common shares trade on the NEX Board of the TSX Venture Exchange under the symbol “TRU.H”.Trius is a portfolio company of Resurgent...

HOUSTON, May 27, 2020 (GLOBE NEWSWIRE) — Par Pacific Holdings, Inc. (NYSE: PARR) (“Par Pacific” or the “Company”) today announced that Par Petroleum, LLC (“Par Petroleum”) and Par Petroleum Finance Corp. (“Finance Corp.” and together with Par Petroleum, the “Issuers”), both wholly-owned subsidiaries of the Company, intend to offer, subject to market and other conditions, $100 million aggregate principal amount of senior secured notes due 2026 (the “Notes”) through a private offering to qualified institutional buyers pursuant to Rule 144A and to certain persons outside of the United States pursuant to Regulation S, each under the Securities Act of 1933, as amended (the “Act”).     The Notes will be secured, senior obligations of the Issuers, and interest will be payable semi-annually in arrears. The Notes will be guaranteed on a...

København, 27. maj 2020I henhold til artikel 19 i EU Regulativ nr. 596/2014 af 16. april 2014 skal EAC Invest A/S indberette oplysninger om ledende medarbejderes og disses nærtståendes transaktioner med EAC Invest A/S’ aktier og tilknyttede værdipapirer.Detaljer fremgår af vedhæftede.Med venlig hilsen,for EAC Invest A/SBestyrelsenFor yderligere informationMartin Thaysen, CEO, Telefon: +45 3525 4300, e-mail investorinformation@eac.dkVedhæftede filerPDMR – Olav W. Hansen AS – 26.05.2020PDMR – Olav W. Hansen AS – 25.05.2020

WEST CHESTER, Pa., May 27, 2020 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for viral skin diseases requiring medical interventions, today announced that Ted White, Verrica President and CEO, will virtually present at the Jefferies 2020 Healthcare Conference. Details for the presentation are included below:Jefferies 2020 Healthcare ConferenceTuesday, June 2nd3:30 PM – 3:55 PM ETA live webcast of the presentation can be accessed at the company’s Investors page under Events and Presentations at https://investors.verrica.com/events-and-presentations.  Webcast replay will also be available on this website shortly after conclusion of the event for 30 days.About Verrica Pharmaceuticals Inc.Verrica is a dermatology therapeutics company developing...

HOUSTON, May 27, 2020 (GLOBE NEWSWIRE) — Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced that management will participate in two upcoming virtual investor conferences.Conference Details:Jefferies Virtual Healthcare ConferenceDate/Time: Wednesday, June 3, 2020 at 4:00 p.m. EDTFormat: Fireside ChatInvestor Summit Virtual Summer SummitDate/Time: Wednesday, June 10, 2020 at 3:20 p.m. EDTFormat: PresentationLive webcasts of the fireside chat and presentation may be accessed from the Events & Presentation section of the Bellicum website. An archived version of each webcast will be available for replay immediately following the event.About Bellicum PharmaceuticalsBellicum is a clinical stage biopharmaceutical company striving to deliver...

STAMFORD, Conn., May 27, 2020 (GLOBE NEWSWIRE) — The Lovesac Company (Nasdaq: LOVE) today announced that its financial results for the first quarter of fiscal 2021 will be released before market open on Tuesday, June 9, 2020. The Company will host a conference call at 8:30 a.m. Eastern Time to discuss the financial results.Investors and analysts interested in participating in the call are invited to dial 877-407-3982 (international callers please dial 201-493-6780) approximately 10 minutes prior to the start of the call. A live audio webcast of the conference call will be available online at investor.lovesac.com.A recorded replay of the conference call will be available within two hours of the conclusion of the call and can be accessed online at investor.lovesac.com for 90 days.About The Lovesac CompanyBased in Stamford, Connecticut,...

PARSIPPANY, N.J., May 27, 2020 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (NASDAQ: PCRX) today reported that it will present at the 2020 Jefferies Virtual Healthcare Conference at 9:30 AM ET on Wednesday, June 3, 2020. Live audio of the event can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of the webcast will also be available for two weeks following the event.About PaciraPacira BioSciences, Inc. (NASDAQ: PCRX) is a leading provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for health care practitioners and their patients. The company’s long-acting local analgesic, EXPAREL® (bupivacaine liposome injectable suspension) was commercially launched in the United States in April 2012. EXPAREL utilizes DepoFoam®,...

SAN DIEGO, May 27, 2020 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, today announced the appointment of Adriana Cabré, MBA, as Vice President of Human Resources.“We are pleased to welcome Adriana to the executive team to lead our Human Resource function,” said Scott Struthers, Ph.D., Founder and Chief Executive Officer of Crinetics. “Adriana’s broad experience across all aspects of human resources, including previously building a commercial endocrinology organization, will be highly valuable as we grow and expand our capabilities. Our employees are our most important competitive advantage and we are committed to preserving the entrepreneurial,...